THE USE OF PHAGOTHERAPY IN THE FIGHT AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the leading causes of hospital infections, notable for its resistance to multiple conventional antibiotics, thus requiring innovative therapeutic alternatives. This study, through an integrative literature review, explores phage therapy as a promising method, using specific bacteriophages to effectively combat MRSA with fewer adverse effects. The analysis covers the mechanisms of action of phages, comparisons with traditional therapies, and clinical trials that reinforce the feasibility of phage therapy as an alternative and effective approach to controlling MRSA.